Derek  McCandless net worth and biography

Derek McCandless Biography and Net Worth

SVP of Cencora
Derek S. McCandless serves as Senior Vice President - Legal, General Counsel, Secretary of the Company. He has served as our Senior Vice President, Legal, General Counsel and Secretary since March 2011. Prior to joining us in March 2011, Mr. McCandless served as Senior Vice President and Assistant General Counsel at Apartment Investment and Management Company, a REIT focused on apartment properties, which he joined in 2003. Prior to his tenure with Apartment Investment and Management Company, Mr. McCandless was in private practice with the law firms of Holme Roberts & Owen LLP (since combined with Bryan Cave Leighton Paisner LLP) and Cooley LLP. Mr. McCandless received a J.D. from The University of Chicago and a B.S., cum laude, from Brigham Young University.

How do I contact Derek McCandless?

The corporate mailing address for Mr. McCandless and other Cencora executives is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. Cencora can also be reached via phone at (610) 727-7000 and via email at [email protected]. Learn More on Derek McCandless' contact information.

Has Derek McCandless been buying or selling shares of Cencora?

Derek McCandless has not been actively trading shares of Cencora during the past quarter. Learn More on Derek McCandless' trading history.

Who are Cencora's active insiders?

Cencora's insider roster includes Silvana Battaglia (EVP), Elizabeth Campbell (EVP), John Chou (EVP), Gina Clark (EVP), Gina Clark (EVP), Steven Collis (CEO), Leslie Donato (EVP), Leslie Donato (EVP), Jeffrey Finnin (CFO), Juan Font (SVP), Jane Henney, MD (Director), Mark Jones (CAO), Maile Kaiser (SVP), Michael Koehler (Director), Lazarus Krikorian (CAO), Aleksandra Krusko (SVP), Robert Mauch (EVP), Robert Mauch (COO), Derek McCandless (SVP), Henry McGee, III (Director), Steven Smith (CRO), Paul Szurek (CEO), and Brian Warren (SVP). Learn More on Cencora's active insiders.

Are insiders buying or selling shares of Cencora?

During the last year, insiders at the sold shares 21 times. They sold a total of 7,622,034 shares worth more than $1,640,810,686.31. The most recent insider tranaction occured on April, 16th when CEO Steven H Collis sold 10,754 shares worth more than $2,553,859.92. Insiders at Cencora own 15.8% of the company. Learn More about insider trades at Cencora.

Information on this page was last updated on 4/16/2024.

Derek McCandless Insider Trading History at Cencora

See Full Table

Derek McCandless Buying and Selling Activity at Cencora

This chart shows Derek Mccandless's buying and selling at Cencora by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cencora Company Overview

Cencora logo
Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
Read More

Today's Range

Now: $240.88
Low: $238.10
High: $241.36

50 Day Range

MA: $238.55
Low: $231.72
High: $245.77

2 Week Range

Now: $240.88
Low: $163.37
High: $246.75

Volume

972,783 shs

Average Volume

1,039,289 shs

Market Capitalization

$48.05 billion

P/E Ratio

26.24

Dividend Yield

0.86%

Beta

0.45